ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,184.46
2.26%
S&P 500
5,483.85
0.11%
Dow Jones
39,168.95
0.11%
US Dollar vs Yen
160.4975
-0.08%
Brent Oil
85.25
0.92%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Oramed Pharmaceuticals Inc (ORMP)

  7. Oramed Pharmaceuticals Inc (ORMP) ニュース

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ORMP
日付受信時刻ニュースソース見出しコード企業名
2024/06/2622 : 05PR Newswire (US)Oramed Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/06/2622 : 00PR Newswire (US)Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common StockNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/06/2020 : 32Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/06/2020 : 30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/06/1106 : 28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/06/1106 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/05/1006 : 00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORMPOramed Pharmaceuticals Inc
2024/05/0622 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/03/1922 : 00GlobeNewswire Inc.Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and InnovationNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/03/0707 : 00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORMPOramed Pharmaceuticals Inc
2024/02/2022 : 42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/02/2022 : 30PR Newswire (US)Oramed Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/3107 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/2406 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/2006 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0906 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2024/01/0303 : 13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
2023/12/2123 : 26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
2023/12/1906 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
2023/11/1007 : 10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP

最近閲覧した銘柄

USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MCD
McDonalds
USOTC
BNPQY
BNP Paribas (QX)
COIN
ETHUSD
Ethereum
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
AMEX
XLE
Energy Select Sector SPDR
CCOM
US500
US 500
NASDAQ
TSLA
Tesla
NYSE
BAC
Bank of America
CCOM
SILVER
SILVER
USOTC
ADDYY
Adidas (QX)
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
FX
USDJPY
US Dollar vs Yen
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有